SAGE: Sage Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 292.41
Enterprise Value ($M) 192.78
Book Value ($M) 551.84
Book Value / Share 9.02
Price / Book 0.53
NCAV ($M) 534.39
NCAV / Share 8.74
Price / NCAV 0.55

Profitability (mra)
Return on Invested Capital (ROIC) -0.60
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.41

Liquidity (mrq)
Quick Ratio 10.02
Current Ratio 10.02

Balance Sheet (mrq) ($M)
Current Assets 604.99
Assets 622.43
Liabilities 70.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
6 days ago 13G/A Bb Biotech Ag 7.30 27.27
8 days ago 13G/A Fmr Llc 8.63 -16.36
8 days ago 13G/A Vanguard Group Inc 9.43 0.00
11-08 13G/A BlackRock, Inc. 8.80 0.00
10-18 13G/A State Street Corp 4.80 -25.32
06-06 13G/A Wellington Management Group Llp 0.07 -99.34
02-14 13G Rtw Investments, Lp 8.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-19 160,890 740,862 21.72
2024-11-18 186,524 717,072 26.01
2024-11-15 227,692 986,802 23.07
2024-11-14 128,661 723,934 17.77

(click for more detail)

Similar Companies
RNAC – Cartesian Therapeutics, Inc. RVNC – Revance Therapeutics, Inc.
RYTM – Rhythm Pharmaceuticals, Inc. SCYX – SCYNEXIS, Inc.
SGMT – Sagimet Biosciences Inc.


Financial data and stock pages provided by
Fintel.io